About 48North Cannabis Corporation
The 48North Cannabis Corp. (USOTC: NCNNF | TSXV: NRTH) is a vertically-integrated cannabis company focused on the health and wellness market through cultivation and extraction, as well as the creation of innovative, authentic brands for next-generation cannabis products. 48North is developing formulations and manufacturing capabilities for its own proprietary products, as well positioning itself to contract manufacture similar products for third parties. 48North operates two indoor-licensed cannabis production sites in Ontario with over 86,000 square feet of production capacity. 48North cultivates unique genetics at its wholly-owned subsidiaries, DelShen Therapeutics Corp. ("DelShen") and 2599760 Ontario Corp. dba Good & Green ("Good & Green"), both Licensed Producers under the Cannabis Act. In addition, 48North expects to operate a 100-acre organic farm - The Good Farm ("Good Farm"), providing 48North with organic, sun-grown cannabis providing a significant first-mover advantage in the production of low-cost, next-generation, extract-based cannabis products. The outdoor operation would yield 40,000 kilograms of cannabis a year. 48North has a growing portfolio of brands that include Latitude, a women's cannabis platform (explorelatitude.com) and Mother & Clone, a rapid-acting sublingual cannabis nanospray (momandclone.com), and F8 (f8te.ca), a high-end cannabis accessory line. 48North has been added to Canada's largest and best performing Cannabis ETF,
Horizons Marijuana Life Sciences Index ETF.
The addition of 48North to the HMMJ signals market validation of the Company’s strong position in the Canadian cannabis industry. 48North’s inclusion, along with a select group of its peers, is a proof-point that the Company is being watched closely by the investment community. Investors are taking note of the disruptive potential that, pending Health Canada’s approval, 48North’s significant outdoor cultivation will have on the industry as a whole.
All you need to know 48North Cannabis Corp. News Releases, OTC: – – – – – – – – – –